ABCAM Plc Directors' Dealings: LTIP (2689W)
06 November 2014 - 3:20AM
UK Regulatory
TIDMABC
RNS Number : 2689W
ABCAM Plc
05 November 2014
For immediate release 5 November 2014
ABCAM PLC
("Abcam" or "the Company")
Director dealing: LTIP
Cambridge, UK: Abcam plc (AIM: ABC), a global leader in the
supply of protein research tools, announces that on 4 November 2014
the Remuneration Committee granted the following share awards in
the form of Nil Cost Options or Conditional Shares (the "Award") to
the Directors of the Company under the Abcam plc Long-Term
Incentive Plan (the "LTIP"):
Director Number of 0.2
pence Ordinary
Shares subject
to the LTIP Award
Alan Hirzel 38,359*
-------------------
Jim Warwick 31,610
-------------------
Jeff Iliffe 34,670
-------------------
* The award made to Alan Hirzel is in the form of conditional
shares which will be delivered following vesting.
The Awards will vest in three years' time subject to continued
employment and subject to a performance condition based on growth
in earnings per share.
For further information please contact:
Abcam + 44 (0) 1223 696 000
Jeff Iliffe, Chief Financial Officer
Numis Securities - Nominated Adviser
& Joint Broker + 44 (0) 20 7260 1000
Michael Meade - Nominated Adviser
James Black - Corporate Broking
Peel Hunt LLP - Joint Broker + 44 (0) 20 7418 8900
Clare Terlouw / Jock Maxwell MacDonald
Brunswick + 44 (0) 20 7404 5959
Justine Mcllroy / Robin Wrench
Notes for editors:
About Abcam plc
Abcam plc is a leading provider of life science research tools
and services, with a wide range of products and expert technical
support, enabling scientists to analyse living cells at the
molecular level and improving the understanding of health and
disease.
Abcam is committed to providing scientists with an extensive
choice of reagents and tools, with the most comprehensive, honest
and up-to-date datasheets and customer reviews, fast delivery and
helpful customer service & technical support. The Company's
catalogue evolves with scientific research trends and is growing
each year to provide customers with products to meet their research
needs. The range now includes primary and secondary antibodies,
proteins, peptides, lysates, biochemicals, immunoassays and other
kits. Abcam also supports its customers by hosting a range of
global scientific events, forums and webinars, providing
opportunities for scientists to get together and present their
work.
Headquartered in Cambridge, UK, Abcam has eight global
subsidiary offices enabling local services, multi-language support
and sells to over 100 countries. The Company was founded in 1998,
and now employs over 740 people. Abcam was admitted to AIM in 2005
(AIM: ABC).
To find out more, please visit www.abcamplc.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSLLFLRLTLEIIS
Abcam (LSE:ABC)
Historical Stock Chart
From Apr 2024 to May 2024
Abcam (LSE:ABC)
Historical Stock Chart
From May 2023 to May 2024